Can-Fite BioPharma Ltd. (CANF)
AMEX·Healthcare·Biotechnology
$2.90
-0.68%
Mkt Cap $2.20M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q3 2025 Aug 28, 2025 | — | $101.00K | — | — | -$0.21 | — | — | — |
| Q2 2025 Apr 14, 2025 | — | $101.00K | — | -$0.24 | -$0.21 | +10.68% | — | — |
| Q4 2024 Dec 26, 2024 | $150.00K | $179.00K | +19.33% | -$0.27 | -$0.43 | -59.26% | — | — |
| Q3 2024 Sep 26, 2024 | $100.00K | $158.00K | +58.00% | -$0.36 | -$0.40 | -11.11% | — | — |
| Q2 2024 Jun 27, 2024 | $150.00K | $158.00K | +5.33% | -$0.40 | -$0.65 | -62.50% | — | — |
| Q1 2024 Mar 28, 2024 | $200.00K | $155.00K | -22.50% | -$5.40 | -$6.20 | -14.81% | — | — |
| Q4 2023 Nov 30, 2023 | $200.00K | $196.00K | -2.00% | -$8.60 | -$8.60 | +0.00% | — | — |
| Q3 2023 Aug 31, 2023 | $200.00K | $196.00K | -2.00% | -$10.80 | -$8.00 | +25.93% | — | — |
| Q2 2023 Jun 1, 2023 | — | $196.00K | — | -$1.52 | -$13.00 | -755.26% | — | — |
| Q1 2023 Mar 30, 2023 | — | $197.00K | — | -$11.40 | -$22.20 | -94.74% | — | — |
| Q4 2022 Nov 25, 2022 | $300.00K | $204.00K | -32.00% | -$20.00 | -$18.00 | +10.00% | — | — |
| Q3 2022 Aug 25, 2022 | $250.00K | $204.00K | -18.40% | -$18.00 | -$16.00 | +11.11% | — | — |
| Q2 2022 May 26, 2022 | $133.33K | $205.00K | +53.75% | -$24.00 | -$18.00 | +25.00% | — | — |
| Q1 2022 Mar 24, 2022 | $266.67K | $204.00K | -23.50% | -$36.00 | -$38.00 | -5.56% | — | — |
| Q4 2021 Nov 26, 2021 | $120.00K | $251.00K | +109.17% | -$20.00 | -$38.00 | -90.00% | — | — |
| Q3 2021 Aug 26, 2021 | $120.00K | $250.00K | +108.33% | -$24.00 | -$38.00 | -58.33% | — | — |
| Q2 2021 May 27, 2021 | — | $148.00K | — | -$34.00 | -$24.00 | +29.41% | — | — |
| Q1 2021 Mar 25, 2021 | — | $150.00K | — | -$26.00 | -$60.00 | -130.77% | — | — |
| Q4 2020 Nov 30, 2020 | — | $211.00K | — | -$50.00 | -$48.00 | +4.00% | — | — |
| Q3 2020 Aug 27, 2020 | $275.40K | $204.00K | -25.93% | -$56.00 | -$60.00 | -7.14% | — | — |